NicOx Announces Initiation Of First Phase 1 Study Of Investigational Nitric Oxide-Donating Agent In Hypertensive Patients By Merck Co., Inc.
Added: 15 мая 2008
Last relative articles:
- O'Keefe Receives Gruber Neuroscience Prize For Discovery Of Place Cells And Their Role In Cognition
- Seminar Focuses On Quality And Safety In Nursing Education, Illinois, USA
- UO Team's Findings Could Pave Way For Synthetic Compounds Useful In Drug Discovery And Materials Science
- Former President George Bush And Barbara Bush Lead C-Change Initiative To Unify Public Education Messages On Cancer Prevention And Early Detection
- Published Study Reveals Next Pharmaceuticals' Flavoxine trade; Reduces Multiple Heart Health Risk Factors Including High Cholesterol
- AquaSlim Helps You Get The Summer You Deserve -- Drink Thin With New AquaSlim
- Market America Announces Plans To Launch Vitamins For Children With Autism
- Wedensky Modulation Identifies Sudden Cardiac Arrest Risk In Patients
- VitalCare's Patient Of The Month Program Launch
- A New Approach To Epilepsy Treatment Takes Its First Steps
Comments: [0] / Post comment:
25 Nov 2008 13:19:55
NicOx announces positive results from Phase III osteoarthritis study - Pharmaceutical Business Review
NicOx announces positive results from Phase III osteoarthritis study Pharmaceutical Business Review - The 303 study is also the final pivotal trial that NicOx plans to include in the submission of a new drug application (NDA) to the FDA in mid-2009. ...
25 Nov 2008 01:07:47
NicOx Jumps to Six-Month High on Naproxcinod Results (Update2) - Bloomberg
NicOx Jumps to Six-Month High on Naproxcinod Results (Update2) Bloomberg - 24 (Bloomberg) -- NicOx SA, the French biotechnology company working with Pfizer Inc. and Merck & Co., jumped to a six-month high in Paris trading after its ... UPDATE 1- NicOx at 6-month high as third trial backs drug Third Pivotal Phase 3 Study for NicOx ' Naproxcinod Shows Positive ... NicOx SA says Third Pivotal Phase 3 Study for Naproxcinod Shows ...
Source: http://bloomberg.com/apps/news
24 Nov 2008 19:32:31
NicOx Clears Another Hurdle For Launching Arthritis Drug - EasyBourse.com
NicOx Clears Another Hurdle For Launching Arthritis Drug EasyBourse.com, France - By Thomas Varela OF DOW JONES NEWSWIRES PARIS (Dow Jones)--Shares of French biotech company NicOx (7413.FR) Monday surged after the company reported that a ...
24 Nov 2008 12:03:25
UPDATE 1-NicOx at 6-month high as third trial backs drug - Hemscott
UPDATE 1- NicOx at 6-month high as third trial backs drug Hemscott, UK - NicOx will now pool the blood pressure data from all three Phase III studies, as previously agreed with the US Food and Drug Administration, and disclose ...
24 Nov 2008 10:39:04
NicOx shares climb on Phase III study of hip drug - MarketWatch
NicOx shares climb on Phase III study of hip drug MarketWatch - By Steve Goldstein , , ) rose as much as 26% in early Paris action as the French firm said that a third Phase 3 study showed that its naproxcinod drug for ...
12 Nov 2008 10:06:49
NicOx' naproxcinod shows highly significant reduction in daytime ... - FOXBusiness
NicOx ' naproxcinod shows highly significant reduction in daytime ... FOXBusiness - NicOx SA (Euronext Paris: COX) today announced that a new analysis of the data from the 104 Ambulatory Blood Pressure Monitoring (ABPM) study for ...
12 Nov 2008 08:16:03
NicOx' naproxcinod shows highly significant reduction in daytime ... - International Business Times
NicOx ' naproxcinod shows highly significant reduction in daytime ... International Business Times, NY - NicOx SA (Euronext Paris: COX) today announced that a new analysis of thedata from the 104 Ambulatory Blood Pressure Monitoring (ABPM) study fornaproxcinod ...
10 Nov 2008 12:59:38
STOCKS NEWS EUROPE-NicOx up as data again backs painkiller - Reuters UK
STOCKS NEWS EUROPE- NicOx up as data again backs painkiller Reuters UK, UK - NicOx (NCOX.PA: Quote, Profile, Research) shares gain 8 percent as further analysis of clinical studies, presented at the American Heart Association in New ...
05 Nov 2008 20:22:19
NicOx reports positive blood pressure data for arthritis drug - Trading Markets (press release)
NicOx reports positive blood pressure data for arthritis drug Trading Markets (press release), CA - Michele Garufi, Chairman and CEO of NicOx , said: "These results are an important addition to the consistent data we are accumulating on naproxcinod's ...
05 Nov 2008 11:47:58
NicOx Announces Favorable Blood Pressure Data For Naproxcinod In A ... - Medical News Today (press release)
NicOx Announces Favorable Blood Pressure Data For Naproxcinod In A ... Medical News Today (press release), UK - NicOx SA (Euronext Paris: COX) announced positive top-line results from a 118 patient Ambulatory Blood Pressure Monitoring (ABPM) trial (the 111 study), ...